BioACCESS contributes to the IAVI Wellcome report on expanding global access to mAb-based products.

BioACCESS took part in consultations and reviewed the IAVI Welcome report, which sets out a roadmap to make lifesaving antibody treatments affordable and available, particularly to those living in low- and middle-income countries. BioACCESS will take part in a series of webinars, virtual meetings, and publications to engage key stakeholders in taking concrete actions to make the recommendations in the report a reality.

Read the report HERE.

Related News